244 related articles for article (PubMed ID: 20179793)
1. Current concepts and future directions in differentiated thyroid cancer.
McLeod DS
Clin Biochem Rev; 2010 Feb; 31(1):9-19. PubMed ID: 20179793
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine refractory differentiated thyroid cancer.
Jin Y; Van Nostrand D; Cheng L; Liu M; Chen L
Crit Rev Oncol Hematol; 2018 May; 125():111-120. PubMed ID: 29650270
[TBL] [Abstract][Full Text] [Related]
3. Surgical options for thyroid cancer and post-surgical management.
Doubleday A; Sippel RS
Expert Rev Endocrinol Metab; 2018 May; 13(3):137-148. PubMed ID: 30058897
[TBL] [Abstract][Full Text] [Related]
4. Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors.
van Santen HM; Alexander EK; Rivkees SA; Frey E; Clement SC; Dierselhuis MP; Lebbink CA; Links TP; Lorenz K; Peeters RP; Reiners C; Vriens MR; Nathan P; Schneider AB; Verburg F
Eur J Endocrinol; 2020 Sep; 183(3):P1-P10. PubMed ID: 32508309
[TBL] [Abstract][Full Text] [Related]
5. A Mobile App for Thyroid Cancer Patients Aiming to Enhance Their Quality of Life: Protocol for a Quasiexperimental Interventional Pilot Study.
Giannoula E; Iakovou I; Katsikavelas I; Antoniou P; Raftopoulos V; Chatzipavlidou V; Papadopoulos N; Bamidis P
JMIR Res Protoc; 2020 Mar; 9(3):e13409. PubMed ID: 32167482
[TBL] [Abstract][Full Text] [Related]
6. Current controversies and future directions in the diagnosis and management of differentiated thyroid cancers.
Ullmann TM; Gray KD; Moore MD; Zarnegar R; Fahey TJ
Gland Surg; 2018 Oct; 7(5):473-486. PubMed ID: 30505769
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Molecular and Theranostic Imaging for Differentiated Thyroid Cancer.
Sheikh A; Polack B; Rodriguez Y; Kuker R
Mol Imaging Radionucl Ther; 2017 Feb; 26(Suppl 1):50-65. PubMed ID: 28117289
[TBL] [Abstract][Full Text] [Related]
8. Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment.
Nickel B; Tan T; Cvejic E; Baade P; McLeod DSA; Pandeya N; Youl P; McCaffery K; Jordan S
JAMA Otolaryngol Head Neck Surg; 2019 Mar; 145(3):231-238. PubMed ID: 30653212
[TBL] [Abstract][Full Text] [Related]
9. Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
Verburg FA; Luster M; Cupini C; Chiovato L; Duntas L; Elisei R; Feldt-Rasmussen U; Rimmele H; Seregni E; Smit JW; Theimer C; Giovanella L
Thyroid; 2013 Oct; 23(10):1211-25. PubMed ID: 23692026
[TBL] [Abstract][Full Text] [Related]
10. Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
Prasad PK; Mahajan P; Hawkins DS; Mostoufi-Moab S; Venkatramani R
Pediatr Blood Cancer; 2020 Jun; 67(6):e28141. PubMed ID: 32275118
[TBL] [Abstract][Full Text] [Related]
11. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
12. ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence.
Sun R; Yang L; Hu Y; Wang Y; Zhang Q; Zhang Y; Ji Z; Zhao D
Oncol Lett; 2020 Nov; 20(5):240. PubMed ID: 32973954
[TBL] [Abstract][Full Text] [Related]
13. RADIOISOTOPE DIAGNOSTIC ALGORITHM FOR THE RELAPSE AND METASTASES DETECTION IN THE IODINE-NEGATIVE DIFFERENTIATED THYROID CANCER.
Solodyannikova OI; Kmetyuk YV; Danilenko VV; Sukach GG
Probl Radiac Med Radiobiol; 2020 Dec; 25():579-591. PubMed ID: 33361863
[TBL] [Abstract][Full Text] [Related]
14. Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series.
Perticone F; Pigliaru F; Mariotti S; Deiana L; Furlani L; Mortini P; Losa M
Thyroid; 2015 Apr; 25(4):417-24. PubMed ID: 25647054
[TBL] [Abstract][Full Text] [Related]
15. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
[TBL] [Abstract][Full Text] [Related]
16. Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC).
Lodi Rizzini E; Repaci A; Tabacchi E; Zanoni L; Vicennati V; Cavicchi O; Pagotto U; Morganti AG; Fanti S; Monari F
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441364
[TBL] [Abstract][Full Text] [Related]
17. Clinically meaningful end points in the evolving treatment paradigm for radioactive iodine-refractory differentiated thyroid cancer.
Sacks W; Braunstein GD
Expert Rev Endocrinol Metab; 2015 May; 10(3):337-344. PubMed ID: 30298771
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based review of treatment and follow up of pediatric patients with differentiated thyroid carcinoma.
Rachmiel M; Charron M; Gupta A; Hamilton J; Wherrett D; Forte V; Daneman D
J Pediatr Endocrinol Metab; 2006 Dec; 19(12):1377-93. PubMed ID: 17252690
[TBL] [Abstract][Full Text] [Related]
19. Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized Medicine.
Matrone A; Campopiano MC; Nervo A; Sapuppo G; Tavarelli M; De Leo S
Front Endocrinol (Lausanne); 2019; 10():884. PubMed ID: 31998228
[TBL] [Abstract][Full Text] [Related]
20. Advancements in the treatment of differentiated thyroid cancer.
Stewart LA; Kuo JH
Ther Adv Endocrinol Metab; 2021; 12():20420188211000251. PubMed ID: 33796254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
